Last update:

Cardiology news

ACC/AHA guidelines updated for dyslipidemia management

In a clinical practice guideline issued by the American College of Cardiology, the American Heart Association, and nine other leading medical associations, updated recommendations are presented for managing dyslipidemia. ...

Fat in muscle hastens limb loss, study shows

For decades, treatment of peripheral artery disease has focused almost exclusively on restoring blood flow. Now, new research from University of Florida scientists suggests that what happens inside the muscle, not just inside ...

Vaping: Emerging harms health systems can't ignore

When e-cigarettes first appeared around 2010, they were hailed as a breakthrough: nicotine delivery without the toxic tar and combustion byproducts of traditional cigarettes. Public health bodies cautiously endorsed them ...

How one receptor can help—or hurt—your blood vessels

Researchers at the University of California San Diego have uncovered how a single protein triggers two opposite responses in blood vessels—one inflammatory and one protective. This protein, a cell-surface receptor called ...

Do gut microbes shape heart health?

For generations, wise aunties and grandmothers have advised that the quickest path to the heart is through the stomach. Our elders also encourage us to trust our guts when it comes to matters of the heart. And they may be ...

The skinny on fat: 'How to eat to avoid chronic diseases'

This is the first celebration of Heart Month (it comes every February) since the release of the updated dietary guidelines for Americans. The new recommendations are meant to represent the most current scientific evidence ...

Unmasking the real sugar threat to kids during heart month

While most parents know to limit candy, the true danger of sugar in a child's diet is often hidden in plain sight. A growing body of research reveals that excessive sugar consumption in childhood is linked to a frightening ...

Discovery could improve immune checkpoint inhibitor safety

For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives. Some of these treatments, such as Keytruda and Opdivo, have become familiar brand names. However, ...

What's next for GLP-1s?

Now that GLP-1 drugs have revolutionized how millions of Americans treat obesity and Type 2 diabetes, scientists are exploring the benefits of using the drugs for a host of other chronic diseases—many with few treatment ...

Japan panel approves stem cell medical products

Japanese government experts endorsed on Thursday ground-breaking projects to manufacture regenerative medicine products to treat heart diseases and Parkinson's, media reports said.

Heart attack study reveals 'survival paradox'

Research from the University of Leicester and NIHR challenges the "one-size-fits-all" approach to heart attack care, adding critical nuance to the debate on sex disparities. A new study involving more than 900,000 patients ...